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The following are highlights from the scientific presenta-
tions of the 8th Annual Congress of the Asia-Pacific
Association of Medical Toxicology, which was held in
Beijing, China, October 2009. Clinicians and researchers
from over a dozen countries attended this meeting, where
more than 100 abstracts were showcased as either oral
platform or poster presentations.
Although it is challenging to distill a whole meeting into a
collection of abstracts, we feel that these selections share
qualities common to all innovative research in our field—
they each compel us to think differently about how best to
care for the poisoned patient.
Collectively, these brief reports also provide a window
into an exciting current development: the emergence of
medical toxicology as a vital subspecialty in many
countries where the burden of poisoning is tremendous.
We hope that these abstracts will encourage Journal of
Medical Toxicology readers to contribute to future
international toxicology meetings and research collabo-
rations worldwide.
For those who are interested, the next congress of the
Asia-Pacific Association of Medical Toxicology will be
held in Hanoi, Vietnam, on November 17 to 19, 2010.
(see http://www.apamt2010.vn/ for details). All presenta-
tion from recent APAMT meetings, and other useful
information, can also be found at http://www.asiatox.org.
1. SYMPATHETIC SKIN RESPONSE (SSR)
AND HEART RATE VARIABILITY IN PATIENTS
WITH ACUTE ORGANOPHOSPHORUS (OP)
POISONING
Sudheera Sammanthi Jayasinghe
(1,2,3), Kithsiri Dedduwa
Pathirana
(3), Kaluthotage Kishanthi Gunasinghe
(2).
1.Department of Pharmacology, Faculty of Medicine, Univer-
sity of Ruhuna, Sri Lanka;
2.South Asian Clinical Toxicology Research Collaboration,
Faculty of Medicine, University of Peradeniya, Sri Lanka;
3Clinical Neuroscience Centre, Department of Medicine,
Faculty of Medicine, University of Ruhuna, Sri Lanka.
Introduction: Some well-defined neurological syndromes
are seen following acute organophosphorus (OP) poisoning.
However, it is not clear whether there is medium to long-
term autonomic nervous system dysfunction. Therefore, we
aimed to examine the autonomic nervous system function
in patients with acute OP poisoning.
Method: A case-control follow-up study was conducted.
Sympathetic skin response (SSR) latency and amplitude of
dominant hand, R-R (heart rate) interval variation during
standing, deep breathing and Valsalva maneuver were
measured in 21 patients with acute OP poisoning around the
time of discharge (participants were otherwise well) and
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DOI 10.1007/s13181-010-0087-51–2 months later. Assessments were performed a mean of 8±
8 days (first assessment) and 46±9 days (second assessment)
from exposure. First assessment was done mean 3±2 days
following cessation of atropine therapy. Twenty-one controls
matched for age and gender were also examined. ANOVA
and Post Hoc comparison were used for the analysis.
Results: The mean ages of cases (and controls) was 31±
13 years and there were 16 males in each group. The mean
HbA1C of cases and controls were 5.2±0.32% and 5.4±
0.51%, respectively. Atropine was commenced on six
patients at peripheral hospital and transferred. All others had
cholinergic features before the commencement of atropine
therapy.Threepatientswereadmittedtotheintensivecareunit
(ICU) during the hospital stay and two were ventilated. All
patients were treatedwithatropine. Nineteen patientsreceived
pralidoxime. The mean latency of SSR in controls, first, and
second assessments of cases was 1,527±125 ms, 1,634±
123 ms, and 1,532±123 ms, respectively (F=4.08 (p<0.05)).
Mean amplitude of SSR in controls, first, and second
assessments of cases were 1.48±1.0 mV, 0.33±0.30 mV,
and 1.05±0.81 mV, respectively (F=12.25, (p<0.01)). Post
Hoc comparison showed statistically significant differences
in amplitude between the controls and the first assessment
(p<0.01), and between the first and the second assessments
(p=0.01). The first assessment latency was also significantly
different from the controls (p<0.05). Heart rate variability
analysis did not show any statistical significant difference
between cases and controls.
Conclusion: Statistically significant amplitude reduction and
prolongation of latency was observed in sympathetic skin
responsesatthetimeofdischarge(mean8daysfollowingacute
exposure to OP) which was not present 1 to 2 months later.
2. ACUTE FORMIC ACID POISONING IN SOUTH
INDIA
Ashish J Mathew, Dae Dalus
Department of Internal Medicine, Medical College Hospital,
Trivandrum, Kerala, India
Introduction: Complications of ingestion of formic acid, the
diluted form of which is used in coagulation of rubber latex, are
not described in literature. Kerala, a state in south-western
India, is well known for its rubber plantations. Easy accessibil-
ity to formic acid makes it susceptible to be used for deliberate
self-harminthisregion.Thisretrospectivestudywasconducted
to study the patterns of presentation and identify the predictors
of morbidity and mortality of acute formic acid poisoning.
Methods: Data regarding patients admitted to the medical
wards from January 2007 to December 2008 (2 years) with
formic acid ingestion were retrieved and analyzed for symp-
toms at presentation, clinical parameters, and complications.
Results: Of the 302 patients (181 males), with a mean age
of 42.78 years (13–85 years), accidental ingestion was
reported in 23 patients (7.6%). The mean time taken for
presentation to our center after consumption was 2.5 h.
Formic acid was mixed in alcohol for consumption by
24.2% patients. Common symptoms at presentation were
vomiting (78.1%), respiratory distress (44%), hematemesis
(42.1%), and hematuria (30.1%). Complications of the
poisoning were oral cavity burns (87.7%), metabolic
acidosis (70.2%), septicemia (51.3%), dysphagia (51%),
esophageal stricture (ES; 32.5%), gastro-intestinal perfora-
tion (GIP; 12.9%), aspiration pneumonia (47.4%), ARDS
(33.8%), acute renal failure (38.7%), chemical pneumonitis
(25.5%), and shock (24.2%). Rare complications were
tracheo-esophageal fistula (four), pneumomediastinum
(two), and chemical injury to the cornea (one). Of the 33
patients who underwent hemodialysis, nine developed deep
vein thrombosis. Logistic regression was employed to
predict morbidity (ES). Metabolic acidosis with pH <7.3
(OR 27.78, 95% CI 3.5–223.2), hematemesis (OR 5.5, 95%
CI 2.7–11.1), and age >40 years (OR 0.976, 95% CI 0.95–
0.99) were independent predictors of morbidity. Hematem-
esis (p=0.000) and melena (p=0.000) had significant
associations with ES. Hematuria (p<0.001), respiratory
distress (p<0.001), hematemesis (p<0.001), and GIP
(p=0.000) at presentation were significantly associated
with mortality.
Conclusion: Easy availability of formic acid should be
curtailed by enforcing statutory limitations in its distribution.
Metabolic acidosis, if taken care of by administration of
sodium bicarbonate intravenously at the local medical centers,
before referring the patient to a tertiary setup, may reduce
mortality and morbidity in acute formic acid poisoning.
Patients with hematemesis or melena, if they survive, should
be followed-up with serial esophageogastroduodenal endos-
copy for diagnosis and early treatment of strictures.
3. FRUCTOSE-1, 6-DIPHOSPHATE (FDP)
AS A NOVEL ANTIDOTE IN YELLOW OLEAN-
DER-INDUCED CARDIAC TOXICITY; PHASE II
AND PHASE III CLINICAL TRIALS
Fahim Mohamed
(1), Indika Gwarammana
(1),
Mark Perera
(1), S.F. Jayamanna
(1), R. Hettiarachchi
(1),
C. Abeysinghe
(1),H. Karunatilake
(1), GA Rathnathilake
(1),
K Narangoda
(1), J.M. Potter
(2), E.K. Southcott
(2),
A.H. Dawson
(1,3), and N. A. Buckley
(1,3)
1.South Asian Clinical Toxicology Research Collaboration,
Faculty of Medicine, University of Peradeniya, Sri Lanka
2.ACT Pathology, Canberra Hospital, Australia
3.Prince of Wales Hospital Clinical School, University of
NSW, Australia
J. Med. Toxicol. (2010) 6:360–366 361Introduction: Fructose-1, 6-diphosphate (FDP) was
s h o w nt ob ee f f e c t i v ei no l e a n d e r - i n d u c e dc a r d i a c
toxicity in dogs. It is widely used for other indications
and regarded as safe. We wished to explore its potential
as an antidote in humans. The Phase II study was to
choose the optimal dose, the phase III study to examine
for effectiveness.
Methods: Phase II: We conducted a double-blind phase
II placebo controlled dose ranging study of four doses
levels of FDP in two rural hospitals. Patients received
one of the four doses of FDP (30, 60, 125, 250 mg/kg)
or placebo (normal saline). At each dose tested, six
subjects received FDP and two placebo. Phase III: This
study is a randomised double blind clinical trial in 240
patients of FDP (250mg/kg loading dose of FDP over 20
minutes followed by 6mg/kg/hr for 24 hours) vs. placebo
in acute yellow oleander poisonings. All patients admitted
to Kurunegala Teaching Hospital are initially resuscitated
following the national guidelines. Consenting patients
with AV block are randomised to receive FDP or placebo.
The primary outcome is the sustained reversion to sinus
rhythm with a heart rate greater than 50/min within 2
hours of the FDP/placebo bolus. Secondary outcomes
include death, reversal of hyperkalaemia on the 6, 12, 18
and 24 hour samples and maintenance of sinus rhythm on
the holter monitor. Analysis will be on intention-to-treat.
Results: Phase II: The FDP was well tolerated and there
were no adverse reactions observed at any dose level.
Our primary outcome measure: the reversion of atrio-
ventricular block to sinus rhythm within 2 hours proved
impractical as most (28/32) patients were transferred for
cardiac pacing in a tertiary hospital within this time
and there was frequent electrical interference with
Holter readings. Favorable dose-related falls were seen
in the serum calcium and potassium within 30 minutes
of the infusion (p=0.09 & p=0.03, ANOVA). These
supported the following in the Phase III study design:
use of the highest bolus dose plus an infusion, conduct
study only in tertiary hospital with pacing facilities, use
normal ECG machine as well as Holter monitors, use
serum potassium as secondary outcome measure.
Phase III: This study has randomised 41 patients since
February 2009 out of 319 oleander self-poisoning
admissions. There have been 5 deaths and no adverse
reactions to FDP. The study remains blinded. An interim
analysis will be conducted after 120 patients.
Conclusions: Our findings from the phase II study
suggested FDP is well tolerated and could have favorable
effects on electrolytes. This study greatly helped to
design a Phase III study well placed to determine the
effectiveness of FDP in oleander induced cardiac toxicity,
which is now progressing well and should be completed
in 2011.
4. MUSHROOM POISONING FOLLOWING
CONSUMPTION OF INOCYBE SPECIES
Shyam P. Lohani, Arjun Subedi, Umesh R. Aryal,
Surath Upadhaya, Saroj Nepal.
Nepal Drug and Poison Information Center, Shamakhushi,
Kathmandu, Nepal
Introduction: Mushroom poisoning is quite frequent in
Nepal during rainy season. Approximately 40 species of
poisonous mushroom are found in Nepal. There are
currently eight recognized classes of mushroom poisonings,
seven of which are caused by specific known toxins. The
mushroom of Inocybe species (Inocybe patouillardii) is the
only muscarine-containing mushroom found in Nepal.
The clinical course of patients with typical muscarinic
presentations after consumption of muscarine-containing
mushrooms is reported.
Methods: A retrospective analysis was done for all calls to
a poison center related to muscarinic symptoms following
mushroom ingestion during the period of July 1998 to June
2008. A total of 77 consecutive cases were reported to
Nepal Drug and Poison Information Center.
Results: Fifty-eight percentage of cases involved female
(n=45) and remaining were male (42%, n=32). Ages
ranged from 4 to 67 years, mean 24.70 (±17.96).
Combinations of nausea, vomiting, diarrhea, abdominal
pain, urination, hypersalivation, bradycardia, hypotension,
lacrimation, blurred vision, and miosis were initial present-
ing symptoms. Time to onset of toxicity ranged from
30 min to 2 h after consumption of mushroom. Treatment
was symptomatic and supportive including intravenous
fluids and atropine intravenously; maximum of 1.8 mg of
atropine was needed for reversal of muscarinic symptoms.
In all cases, full recovery occurred within 10 h post
exposure.
Conclusion: Supportive and symptomatic treatment along
with atropine for patients with ingestion of muscarine-
containing mushrooms resulted in a favorable outcome.
5. QRS AND QTc ELECTROCARDIOGRAM (ECG)
DURATIONS IN PATIENTS PRESENTING WITH
ACUTE COCAINE AND COCAETHYLENE TOXICITY
David M Wood
(1,2), Shaun L Greene
(1), Paul I Dargan
(1,2).
1.Clinical Toxicology, Guy’s and Thomas’ NHS Foundation
Trust, London, UK;
2. King’s Health Partners, London, UK.
Introduction: QRS and QTc prolongation, and associated
cardiac arrhythmias, following cocaine use are due to cocaine-
related cardiac ion channel dysfunction. The simultaneous use
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cocaethylene metabolite, which has greater binding to cardiac
ion channels and potentially therefore greater risk of cardiac
arrhythmias. The effects of simultaneous cocaine–ethanol use
on the QRS and QTc duration compared to those seen with
lone cocaine use have not been reported.
Methods: A 24-month retrospective review of patients with
acute toxicity related to self-reported lone cocaine or
simultaneous cocaine–ethanol use was undertaken. Data
on the sex, presenting symptoms/signs and physiological
parameters were extracted on these presentations. ECGs
were reviewed for all presentations, where available, and
QRS duration and QTc calculated using Bazett’s formula
were extracted. Comparison of the QRS and QTc durations
was undertaken between the two groups.
Results: There were 48 and 31 presentations with acute
toxicity related to self-reported simultaneous cocaine–ethanol
use and self-reported lone cocaine use, respectively. There was
no significant difference in the mean (SD) age of those with
simultaneous cocaine–ethanol use (29.8±10.2 years) com-
paredtothosewithlonecocaineuse(29.3±7.7years;p=0.80).
There were no significant differences between the mean (SD)
heart rate (p=0.90), systolic blood pressure (p=0.81), and
temperature (p=0.61) in the simultaneous cocaine–ethanol
and lone cocaine use groups. The mean (SD) QRS and
QTc durations were 87.3±10.8 ms (range 60–108) and
397.4±32.0 ms (range 323–484) for the simultaneous
cocaine–ethanol use and 86.9±12.5 ms (range 67–126)
and 396.2±34.6 ms (317–488) for lone cocaine use
groups (p=0.87 and p=0.88, respectively). There were no
QTc or QRS related cardiac arrhythmias in either group.
Conclusions: In thisstudy, we have not detecteda significant
difference in the QRS and QTc durations between those self-
reported simultaneous cocaine–ethanol use compared to those
with lone cocaine use. Further studies are needed correlate the
concentrations of cocaine and its metabolites, including
cocaethylene, to confirm the findings seen in vitro and animal
models of cardiac ion channel dysfunction.
6. PHENYLPROPANOLAMINE POISONING
DUE TO THE USE OF COLD PREPARATIONS IN
VIETNAM
Chinh Nguyen Dam, Nguyen Trung Nguyen, Due Pham
Poison Control Center, Bach Mai hospital, Hanoi, Vietnam
Introduction. Phenylpropanolamine (PPA) which is often
combined with acetaminophen in cold preparations has
been known to cause many adverse effects including
cardiovascular involvement and is an independent risk
factor for hemorrhagic stroke in women. This study
described prospectively the features of its poisoning.
Method. This is a prospective and descriptive study
performed in patients who get sick after the use of cold
preparation containing phenylpropanolamine and is treated at
our poison control center from September 2002 to September
2005. The poisoning or adverse effects are considered if the
drugs were used very recently(within 6h after the lastdose) in
a previously healthy person. The clinical and laboratory
parameters were evaluated and monitored if exist. PPA-
poisoned patients were treated symptomatically and dis-
charged when all the signs and symptoms resolve.
Results. Forty-six patients including 21 males (45.7%) and 25
females (54.3%) were enrolled. The age of the patients was
32.89±10.13 (range, 17–55 years). Rhumenol® (Tenamyd,
Canada, 30 mg phenylpropanolamin per tablet) and Decolgen
Forte® (United Pharma, 25 mg phenylpropanolamin per tablet)
w e r et w om o s tc o m m o np r o p r i e tary products leading to PPA
poisoning, 95.65%. The reason for taking medicine was self-
treatment of cold: 43/46 cases (93.5%), 37 patients (80.4%)
presented symptoms of PPA poisoning at the first dose of PPA.
Thirty-three cases (71.7%) got poisoning at doses of PPA equal
or less than 60 mg. The symptoms of PPA poisoning were:
headache (93.5%), nausea (50%), dizziness (37%), and ele-
vated systolic blood pressure (higher than 140 mmHg; 95.7%);
bradycardia (39.1%); hypokalemia was presented in 11 patients
(23.3%). Adalat (oral liquid nifedipin) was given with doses of
3–10mg.All the patients recovered fromhypertensionafter7.6
±5.03h,43cases(93.5%)weredischargedontheadmittedday.
No complications of hypertension or death were observed.
Conclusions. The manifestations of PPA poisoning include
acute hypertension, which happens even if patients take the
recommended dose of PPA for cold management. Poisoned
patients recover quickly after PPA discontinuation and the use
of a simple and rapid acting antihypertensive agent. The result
from this study contributed to the decision by the ministry of
health of Vietnam to remove all the pharmaceutical agents
containing phenylpropanolamine from the domestic market
since 2003.
7. PUFFERFISH POISONING—A LARGE
OUTBREAK IN BANGLADESH
Quazi Tarikul Islam
(1), Md. Azizul Haque
(2),M o h a m m e d
Aminur Razzak
(2), Md. Ariful Islam
(2), Md. Iqbal Bari
(2),
Ariful Basher
(3), Ulrich Kuch
(4), H A M Nazmul Ahsan
(1),
Dietrich Mebs
(5),M .A b u lF a i z
(3)
1. Dhaka Medical College Hospital, Dhaka, Bangladesh
2. Rajshahi Medical College Hospital, Rajshahi, Bangladesh
3.Sir Salimullah Medical College & Mitford Hospital, Dhaka,
Bangladesh
4.Biodiversity and climate research centre, Frankfurt, Germany
5. Zentrum der Rechtsmedizin, Goethe University, Frankfurt
am Main, Germany.
J. Med. Toxicol. (2010) 6:360–366 363Introduction: The study was carried out in the Medicine
and Pediatrics department of Rajshahi Medical College
Hospital, and Natore Sadar Hospital, both are located in the
northern territory of Bangladesh.
Methods: On8thJune2008,83patients(male50,female33)
of Singra Upazila Natore were admitted in Rajshahi Medical
College Hospital and Natore Sadar Hospital with the history
of consumption of Puffer fish. A presumptive diagnosis of
Puffer fish poisoning was made on the basis of classical
clinicalpresentationsfollowedby Puffer fishingestion. Blood
and urine sample were taken from 38 patients and sent for
toxicological analysis to Frankfurt, Germany.
Results: Important symptoms observed were peri-oral
paresthesia (71), tingling over entire body (50), nausea and
vomiting (43), dizziness (35), headache (20), and abdominal
pain (13). Muscular paralysis of the limbs was noted in 13
patients, of which seven patients developed respiratory
involvement. All the patients who developed respiratory
involvement died. Out of 83 patients, 76 patients were
improved with conservative management and seven patients
died. Out of 38 blood samples sent for toxicological analysis,
27 patients had detectable levels of Tetrodotoxin (TTX) in
their blood, and in 11 patients blood TTX level was not
detectable (<1.6 ng/ml). Blood TTX level seems to have a
strong correlation with development of neuromuscular
paralysis. Average TTX concentration in patients who
developed neuromuscular paralysis was 8.1 ng/ml.
Conclusion: Early diagnosis and supportive management
could ensure a safe and favorable outcome. Although Puffer
fish poisoning is uncommonly encountered in our daily
practice, physicians should be familiar with the clinical
presentations and management and get prepared to handle
such potentially life-threatening intoxications.
8. LOW MOLECULAR WEIGHT HEPARIN
OVERDOSE
Adeline Ngo Su-Yin, Daryl Tan Chen Lung, Kent R Olson
California Poison Control System-San Francisco Division,
San Francisco, USA
Introduction
Low molecular weight heparin (LMWH) has been used for
the treatment and prevention of several disorders including
deep vein thrombosis, pulmonary embolism, unstable angina,
and myocardial infarction. Its anticoagulant effect cre-
ates the potential for bleeding. There are several studies
showing the risk of major bleeding from therapeutic
anticoagulant use but there have been no reports in the
literature on acute overdose in adults to date.
As the California Poison Control Centre (PCC) has been
consulted on several cases of LMWH overdose, this series
aimed to provide data that may help poison center practice.
We also believe this to be the first case series of patients
reported with an acute overdose on LMWH.
Method
A retrospective chart review of PCC database: Visual Dot
Lab between 1997 and 2007 was obtained. Inclusion
criteria included all patients with a reported overdose on
LMWH. The route of exposure is subcutaneous. Cases
were excluded if therapeutic doses of LMWH were
administered.
Results
There were 21 patients (mean 42.4 years).
The reasons for overdose include medical miscalculation
(three cases, all infants), intentional misuse (two patients),
accidental overdose (seven cases), suicidal attempt (seven
cases), and unknown in two patients.
Seven cases were documented to have overdosed more than
two times the therapeutic dose. The overdose ranged from
0.1 to 80 times the therapeutic range. No patients were
documented to have bleeding or thrombocytopenia. Six
patients were documented to have no bleed and were well
after at least 36 h.
Reassurance was given to patients with less than 0.14 times
the therapeutic dose. Two patients in the series received
protamine because they received more than 2.5 times the
therapeutic dose of LMWH.
Conclusion
Given the rarity of overdose, there is no clear consensus on
its management. Most patients had no complications and
were not treated with protamine. This series suggests that a
large dosage of LMWH is unlikely to result in any life-
threatening complications.
9. ROTUNDIN POISONING IN VIETNAM
Thu Hong Be, Due Pham
Poison Control Center, Bach Mai hospital, Hanoi, Vietnam
Introduction: Rotundin (L-tetrahydropalmatin) was
extracted from the plant Stephania rotunda which has been
known for the sedative and analgesic effects and used
widely in Vietnam. However, this agent has been increas-
ingly used without prescription and the incidence of
poisoning ensued as a result.
Methods: This is a prospective descriptive study. All the
patients overdosed with rotundin (by history and sample of
medications from the patients), with the urine or gastric
fluid positive with rotundin by thin layer chromatography
were admitted to our poison control center from December
2003 to January 2005.
Results: 122 patients (27 males, 22.1% and 95 females,
77.9%) were included. Age of the patient, 23.6±6.3 (12–
364 J. Med. Toxicol. (2010) 6:360–36652 years), reasons for poisoning was suicide in 120 patient
(98.4%). The mean dose was 1,258.7±1,082.81 mg (range,
300–6,000 mg). Severity of poisoning: mild, 69.7%; moder-
ate, 25.4%; severe, 2.5% and no death occurred. The most
common symptoms were CNS depressant (32.8%), nausea
(22.1%), vomiting (20.5%), sinus bradycardia (3.3%), and
hypotension (0.8%). ECG abnormalities accounted for 74.6%
of the patients including prolonged QT (27%), sinus extra-
systole (3.3%), and first degree AV block (1.6%). Sinus
bradycardia, sinus tachycardia, elevated ST segment, and T
wave inversion were also observed. Very mild elevation in
ASTand ALTwere seen in 7.4% of the patients. The dose of
rotundin was 77.8±474.09 mg in patients with normal ECG
and 1,432.0±1,185.8 mg in patients with ECG abnormalities
(p=0.004). The dose of rotundin was 1,172.0±1,026.67 mg
in totally conscious patients and was 1,346.9±1,139.23 mg
in patients with CNS depressant (p=0.385).
Conclusion: Rotundin only causes mild CNS inhibition (if
any). However, in our patients, it also causes cardiac
abnormalities which associate with higher doses.
10. DIAGNOSTIC IMAGING OF OPIUM BODY
PACKING
Zare GA, Balali-Mood M.
Medical Toxicology Research Centre, Imam Reza Hospital,
Mashhad University of Medical Sciences, Mashhad 91735-
348, Khorassan, IR Iran.
Objective: Opium body packing is a common cause of
admission to our Medical Toxicology ward. Since the body
packers are drug smugglers, they are mostly brought to the
hospital by police. Those who are alert usually deny body
packing. Ultrasonography, plain X-ray, and CT scan are
recommended for the diagnosis of body packing and
stuffing. It was aimed to compare the diagnostic values of
the three techniques in opium body packing.
Methods: A questionnaire was designed to record all clinical
and paraclinical findings of all body packers admitted to the
ward between 10 October 2000 and 11 October 2008.
Ultrasonography, plane X-ray, and CT scan were performed
for all body packers on admission and at certain intervals as
clinically indicated. Magnesiumsulfate was used as a cathartic
in all admitted body packers; naloxone was administered in
symptomatic patients. The asymptomatic cases were under
close observation both medically and forensically. The packets
recovered in the feces were counted, weighted, and collected
by the police. The comatose patients with many packets who
did not respond to the medical treatment or revealed bowel
obstruction consulted surgically. The surgically removed
packets were also counted, weighted, and collected by the
police. The results of the three techniques were compared with
the clinical findings and the number of recovered packets.
Statistical analysis (Chi square test) was made using SPSS.
Results: Out of 3,281 poisoned patients admitted to the ward
over the years, 490 patients (15%) had narcotic poisoning, of
which 50 patients (5%) were opium body packers. There were
two female body packers (a 16-year-old girl and a 35-year-old
woman), one of whom had severe opium poisoning; she
underwent emergent surgery and died a day later in ICU.Out of
48malepatients,two(30and69yearsold)alsohadsurgeryand
died. The other 47 patients aged 17 to 58 (mean 31) years were
treated medically and all survived despite the severe intoxica-
tion in 18 of them. The body packers were either illiterate
(28%), primary educated (32%), or secondary educated (40%).
More than 44% of them were drug addicts. The number of
packetsvariedbetween1and 48 (mean of21)withweightsof6
to 102 g (mean of 46). Ultrasonography did not show any clear
countable packets, whereas plain abdominal X-ray revealed the
packets in 24 patients (48%) and abdominal CT scan were
positive in 48 (96%) patients (p<0.001).
Conclusion: (1) Ultrasonography is of no value in
diagnosis of opium body packing. (2) Plane abdominal X-
ray is simple but not efficient. (3) CT scan is the best
diagnostic technique in opium body packing.
11. CENTIPEDE ENVENOMATION IN THAILAND
Rittirak Othong
(1), Winai Wananukul
(2).
(1) Department of Emergency Medicine, Bangkok Metropolitan
Administration Medical College and Vajira Hospital, Bangkok,
Thailand.
(2) Department of Medicine, Ramathibodi Hospital, Bangkok,
Thailand.
Introduction: Centipede envenomation occurs commonly
in tropical countries. At the present time, however, there are
no epidemiologic or clinical studies of centipede enveno-
mations in Thailand. This study is the first of its kind
studying epidemiology, clinical manifestations, and various
treatments of envenomations by centipedes in patients
registered at the Department of Emergency Medicine,
Bangkok Metropolitan Administration Medical College
and Vajira Hospital, Bangkok, Thailand.
Method: We retrospectively analyzed 104 cases of definite
envenomations by centipedes among patients that presented
to the hospital, between 1 January, 2004 and 30 June, 2009.
Demographic data, data on local and systemic effects, and
treatments after centipede envenomations were collected.
Results: There were 104 cases included in this study. Fifty-
two percent were female. Mean age was 27.8±17.8 years
old (ranging from 1 month to 76 years). The time from
envenomation to presentation at the Emergency Department
ranged between 15 min and 48 h (median=40 min). Most
J. Med. Toxicol. (2010) 6:360–366 365of the envenomations (85.9%) occurred at night time
between 6 pm and 6 am. The incidence of envenomations
was highest in the summer months; April and May, and
winter months; October through December. Envenomation
sites were recorded in 96% of patients, and 91 out of 100
cases were stung only once. Feet (32%) and hands (25%)
were the parts of the body most often envenomated. Local
effects were common. Ninety-six percent of patients had
localized pain and 78% had swelling at the site of
envenomation. Systemic effects consisted of nausea
(7.7%), vomiting (5.8%), rash (2.9%), fever (1.9%),
systemic swelling (1.9%), abdominal pain (1%), palpita-
tions (1%), and wheezing (1%). Anaphylaxis was diag-
nosed in three patients with two or more systemic effects,
but neither wheezing lungs nor shock was found. For pain
control, 98.1% received analgesic drugs, while 33.7% were
injected with local anesthesia. Antibiotics, antihistamines,
and steroids were prescribed in 73.1%, 24%, and 9.6%,
respectively. Fortunately, no deaths occurred in this study.
Conclusion: Most of the centipede envenomations we see in
Thailand occur in two clusters each year. The first cluster is in
April and May and the second is in October through
December. Patients were the most vulnerable to centipede
envenomationsduringthenighttimehours.Nearlyallpatients
had local effects, in contrast to systemic effects which rarely
presented. Most of the patients had favorable outcome.
12. A CASE OF OPTHALMIC INJURY
BY SPITTING CHINESE COBRA TREATED
WITH LOCAL ANTIVENOM
S H Ng, Y C Chan, M L Tse
Hong Kong Poison Information Centre, Hong Kong Special
Administrative Region, China.
Introduction: Opthalmic injury by the venom of Chinese
Cobra (Naja atra) is an uncommon but well-recognized
mode of injury. The clinical value of local antivenom for
this type of injury is uncertain although animal studies
showed possible benefits. We report a case of ocular injury
by spitting Chinese Cobra with rapid relief of symptoms
after local antivenom irrigation.
Case Report: A 50-year-old man had left eye injury by a
spitting Chinese Cobra at a 3 ft distance and attended the
Accident and Emergency Department 30 min later. He had
persistent symptoms with left eye pain and blurred vision after
local irrigation with copious amount of normal saline solution.
Examination showed bilateral eye congestion, visual acuity
was 6/21 on the left eye compared with 6/9 on rightside.There
was no corneal abrasion. Naja Antivenin® (Shanghai Institute
of Biological Products, Ministry of Health, China) diluted to
500-mL normal saline irrigation was performed for persistent
symptoms. The patient had relief of his symptoms almost
immediately after irrigation with the diluted antivenom.
Topical antibiotic solutions containing polymyxin, neomycin,
and gramicidin (tetracycline eyedrop was not available in our
center) was also given and his left eye congestion and visual
acuity improved overnight. He remained asymptomatic on
assessment by ophthalmologist 3 days after the injury.
Discussion: It is generally believed that the cardiotoxin
component of the venom of the Cobra family causes ocular
injury. Local toxicities reported for other species of Cobra
ranges from pain, redness, corneal injury to blindness. Animal
model and case reports had showed possible beneficial effect
from the use of tetracycline eyedrops and local administration
of antivenom. Although the role of local administration of
antivenom is controversial for other species of Cobra, the
antivenom used was not specific in other parts of the world. On
the contrary, the Naja Antivenin® is specific to Chinese Cobra
and it is possible that treatment with the antivenom is more
specific. In fact, local antivenom eyedrop has been used for
ocular injury by Chinese Cobra in some centers in China with
good outcome.
Conclusion: Apart from irrigation by water or normal saline
solution, andapplicationof local antibiotics,the administration
of local antivenom, either as eyedrops or in diluted irrigation
can be considered in cases of ocular injury by spitting Chinese
Cobra with persistent symptoms or severe injury.
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